Methadone Dosing Recommendations for Treatment of Chronic Pain
暂无分享,去创建一个
[1] G. Tucker,et al. The pharmacokinetics of methadone in healthy subjects and opiate users. , 2003, British journal of clinical pharmacology.
[2] R. Gebhardt,et al. Conversion From Intrathecal Morphine to Oral Methadone , 2001, Regional Anesthesia & Pain Medicine.
[3] F. Fulfaro,et al. Switching from morphine to methadone to improve analgesia and tolerability in cancer patients: a prospective study. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[4] E. Kalso,et al. Morphine and alternative opioids in cancer pain: the EAPC recommendations , 2001, British Journal of Cancer.
[5] Mellar P. Davis,et al. Methadone for relief of cancer pain: a review of pharmacokinetics, pharmacodynamics, drug interactions and protocols of administration , 2001, Supportive Care in Cancer.
[6] G. Tucker,et al. Population-based pharmacokinetic approach for methadone monitoring of opiate addicts: potential clinical utility. , 2000, Addiction.
[7] D. Bridge,et al. The rediscovery of methadone for cancer pain management , 2000, The Medical journal of Australia.
[8] N. Hagen,et al. Methadone: outpatient titration and monitoring strategies in cancer patients. , 1999, Journal of pain and symptom management.
[9] S. Mercadante,et al. Rapid switching from morphine to methadone in cancer patients with poor response to morphine. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[10] I. Trocóniz,et al. Methadone: a review of its pharmacokinetic/pharmacodynamic properties. , 1999, Journal of pharmacological and toxicological methods.
[11] E. Bruera,et al. Role of methadone in the management of pain in cancer patients. , 1999, Oncology.
[12] E. Bruera,et al. Differences in the ratios of morphine to methadone in patients with neuropathic pain versus non-neuropathic pain. , 1999, Journal of pain and symptom management.
[13] K. Foley,et al. Methadone in cancer pain management: individualize dose and titrate to effect. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[14] C. Brunelli,et al. Switching from morphine to oral methadone in treating cancer pain: what is the equianalgesic dose ratio? , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[15] M. Makin,et al. The use of methadone in cancer pain poorly responsive to other opioids , 1998 .
[16] E. Bruera,et al. Dose ratio between morphine and methadone in patients with cancer pain , 1998, Cancer.
[17] E. Zecca,et al. An update on the clinical use of methadone for cancer pain , 1997, Pain.
[18] P. Narang,et al. Lack of a pharmacologic interaction between rifabutin and methadone in HIV-infected former injecting drug users. , 1996, Drug and alcohol dependence.
[19] E. Zecca,et al. Clinical experience with oral methadone administration in the treatment of pain in 196 advanced cancer patients. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[20] E. Bruera,et al. Opioid rotation in patients with cancer pain: A retrospective comparison of dose ratios between methadone, hydromorphone, and morphine , 1996, Cancer.
[21] J. Gardner-Nix. Oral methadone for managing chronic nonmalignant pain. , 1996, Journal of pain and symptom management.
[22] E. Bruera,et al. Custom-made capsules and suppositories of methadone for patients on high-dose opioids for cancer pain , 1995, Pain.
[23] Kay Wright. Therapeutics in Terminal Cancer, 2nd Edition R Twycross S Lack Therapeutics in Terminal Cancer, 2nd Edition Churchill Livingstone 238pp £12.95 0-443-04118-0 , 1990 .
[24] D. Denson,et al. Pharmacokinetics of Continuous Intravenous Infusion of Methadone in the Early Post‐Burn Period , 1990, Journal of clinical pharmacology.
[25] L. Grochow,et al. Does intravenous methadone provide longer lasting analgesia than intravenous morphine? A randomized, double-blind study , 1989, Pain.
[26] J. Plummer,et al. Estimation of methadone clearance: application in the management of cancer pain , 1988, Pain.
[27] W. Colburn,et al. Pharmacokinetics and pharmacodynamics of methadone in patients with chronic pain , 1987, Clinical pharmacology and therapeutics.
[28] M. Cousins,et al. A comparative study of the efficacy and pharmacokinetics of oral methadone and morphine in the treatment of severe pain in patients with cancer , 1986, Pain.
[29] Levy Mh,et al. Pain management in advanced cancer. , 1985, Seminars in oncology.
[30] P. Hartvig,et al. Clinical Evaluation of Oral Methadone in Treatment of Cancer Pain , 1982, Acta anaesthesiologica Scandinavica. Supplementum.
[31] M. Kreek,et al. Methadone disposition in patients with chronic liver disease , 1981, Clinical pharmacology and therapeutics.
[32] G. Hanks,et al. Patient-controlled dose regimen of methadone for chronic cancer pain. , 1981, British medical journal.
[33] A. Schecter,et al. Methadone use in patients with chronic renal disease. , 1980, Drug and alcohol dependence.
[34] E. Änggård,et al. Pharmacokinetics of methadone during maintenance therapy: Pulse labeling with deuterated methadone in the steady state , 1979, European Journal of Clinical Pharmacology.
[35] D. Ettinger,et al. Important clinical pharmacologic considerations in the use of methadone in cancer patients. , 1979, Cancer treatment reports.
[36] P. Symonds. Methadone and the elderly. , 1977, British medical journal.
[37] N. Gerber,et al. Clinical eftects and pharmacokinetics of racemic methadone and its optical isomers , 1977, Clinical pharmacology and therapeutics.
[38] J. Volavka,et al. Methadone in man: Pharmacokinetic and excretion studies in acute and chronic treatment , 1975, Clinical pharmacology and therapeutics.
[39] C. Inturrisi,et al. Disposition of methadone in man after a single oral dose , 1972, Clinical pharmacology and therapeutics.
[40] K. Wolff,et al. Steady-state pharmacokinetics of methadone in opioid addicts , 2004, European Journal of Clinical Pharmacology.
[41] J. Ufkes,et al. Pharmacokinetics of methadone and its primary metabolite in 20 opiate addicts , 2004, European Journal of Clinical Pharmacology.
[42] E. Änggård,et al. Pharmacokinetics of methadone in methadone maintenance treatment: Characterization of therapeutic failures , 2004, European Journal of Clinical Pharmacology.
[43] E. Änggård,et al. Pharmacokinetics of methadone during maintenance treatment: Adaptive changes during the induction phase , 2004, European Journal of Clinical Pharmacology.
[44] E. Bruera,et al. Equianalgesic dose/ratio between methadone and other opioid agonists in cancer pain: comparison of two clinical experiences. , 1998, Annals of oncology : official journal of the European Society for Medical Oncology.
[45] J. Morley,et al. Comments on Ripamonti et al., Pain, 70 (1997) 109-115. , 1997, Pain.